Optimizing Treatment of Women’s Cancers

  • Primary Objective
    • Optimize the use of current cytotoxic agents alone and in combination and promote the development of new targeted therapies for the treatment of ovarian cancer, endometrial cancer, and cervical cancer.
  • Current Studies
    • Appropriate dosing of chemotherapy agents in obesity
    • Compare and contrast efficacy of Doxil to generic liposomal doxorubicin
    • Modulation of acquired and inherent drug resistance
  • Long-term Goals
    • Improving treatment outcomes with better overall response rates and reducing treatment-related side effects for women with cancer